These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23961654)

  • 1. [Striving for individual therapy].
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():40-1. PubMed ID: 23961654
    [No Abstract]   [Full Text] [Related]  

  • 2. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment for adults with HIV infection.
    Samuel M; Winston A; Peters B
    BMJ; 2015 Apr; 350():h1555. PubMed ID: 25908648
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis B].
    Mauss S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
    Kalichman SC
    Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of late-presenting patients with HIV infection.
    Rockstroh JK; Gatell J; Landman R; Antinori A
    Antivir Ther; 2010; 15 Suppl 1():25-30. PubMed ID: 20442458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved long-term success. New nucleoside for once daily combinations].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():31-3. PubMed ID: 15373043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].
    Kuhlmann B; Trein A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():72-3. PubMed ID: 15373057
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.
    Pujades-Rodríguez M; Schramm B; Som L; Nerrienet E; Narom P; Chanchhaya N; Ferradini L; Balkan S
    Trop Med Int Health; 2011 Feb; 16(2):205-13. PubMed ID: 21087376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 14. Odefsey--another NNRTI combination for HIV.
    Med Lett Drugs Ther; 2016 May; 58(1494):60-1. PubMed ID: 27148923
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy.
    Vento S; Garofano T; Renzini C; Casali F; Ferraro T; Concia E
    AIDS; 1998 Jan; 12(1):116-7. PubMed ID: 9456265
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis C in HIV coinfection].
    Boesecke C; Rockstroh JK
    MMW Fortschr Med; 2012 May; 154 Suppl 1():42-4. PubMed ID: 22916601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interview with Dr. med. Nazifa Qurishi, Köln, and with Siegfried Schwarze, Berlin. HIV therapy from the viewpoint of a physician and of a patient].
    Qurishi N; Schwarze S
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():41. PubMed ID: 23961655
    [No Abstract]   [Full Text] [Related]  

  • 18. [In HIV-HCV co-infection check for drug interactions].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():62. PubMed ID: 27259910
    [No Abstract]   [Full Text] [Related]  

  • 19. [HIV/HCV coinfection. A good chance of recovery also for dually infected patients].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():7. PubMed ID: 25026843
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.